Clinical trial
"Effect of Adding Low-dose Intrathecal Dexmedetomidine to Hyperbaric Bupivacaine on the Duration and Quality of Spinal Anesthesia in Knee Arthroplasty."
NCT07807020 is registered in ClinicalTrials.gov with Shifa International Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- "Effect of Adding Low-dose Intrathecal Dexmedetomidine to Hyperbaric Bupivacaine on the Duration and Quality of Spinal Anesthesia in Knee Arthroplasty."
- Lead sponsor
- Shifa International Hospital
- Phase
- Phase 1/2
- Overall status
- Enrolling by invitation
- Start date
- May 4, 2026
- Completion date
- May 4, 2027
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
intrathecal dexmedetomidine